24 Results for "

current amplitudes

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "current amplitudes" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-110175
CAS No.: 191744-13-5
Purity:  99.94%
Target:  

iGluR

Research Areas:  

Neurological Disease

CX614 is a positive variant modulator of AMPA receptors that enhances excitatory postsynaptic potentials (amplitude and duration) by blocking and slowing the inactivation of responses to glutamate and automatically evokes excitatory postsynaptic currents in neuronal cultures. CX614 can be used in the study of psychiatric disorders such as depression .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108588
CAS No.: 426834-69-7
Purity:  99.92%
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

NS5806, a potent potassium current activator, increases KV4.3/KChIP2 peak current amplitudes with an EC50 of 5.3 μM. NS5806 slows KV4.3 and KV4.2 current dacay in channel complexes containing KChIP2 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124702
CAS No.: 316146-57-3
Purity:  99.25%
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

ICA-105574 is a potent and efficacious hERG channel activator. The primary mechanism by which ICA-105574 potentiates hERG channel activity is by removing hERG channel inactivation. ICA-105574 steeply potentiates current amplitudes more than 10-fold with an EC50 value of 0.5 +/- 0.1 μM and a Hill slope (n(H)) of 3.3 +/- 0.2. ICA-105574 can prevent arrhythmias induced by cardiac delayed repolarization. ICA-105574 shortens action potential duration in ventricular myocytes concentration-dependently .
loading...
    loading...
Cat. No.: HY-P11117
CAS No.: 2899218-49-4
Research Areas:  

Neurological Disease

TAT-EE3 is a neuroprotective peptide which can uncouple TRPM2-NMDARs interaction. TAT-EE3 inhibits TRPM2-induced enhancement of NMDAR surface expression and current amplitude.TAT-EE3 protects neurons against ischemic injury in vitro and in vivo. TAT-EE3can be used for the study of ischemic stroke .
loading...
    loading...
Cat. No.: HY-N6688
CAS No.: 12771-72-1
Verruculogen is a tremorgenic mycotoxin and inhibitor of the M phase of the mammalian cell cycle. Verruculogen is produced by Penicillium and Aspergillus species. Verruculogen enhances the binding of ChTX to maxi-k channels with a K1/2 value of 170 nM. Verruculogen inhibits the amplitude of Ca 2+-activated K + currents. Verruculogen induces severe tremors in infected animals .
loading...
    loading...
Cat. No.: HY-110162
CAS No.: 1259536-62-3
Purity:  99.01%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

QO 58 is a potent modulator of K(v)7 channels. QO-58 increases the current amplitudes, shifts the voltage-dependent activation curve in a more negative direction and slows the deactivation of K(v)7.2/K(v)7.3 currents. QO-58 has the potential for the research of diseases associated with neuronal hyperexcitability .
loading...
    loading...
Cat. No.: HY-108592
CAS No.: 918311-87-2
Purity:  98.91%
UCL 2077 is a potassium channel and slow afterhyperpolarization (sAHP) inhibitor. UCL 2077 selectively blocks sAHP channels without affecting L-type Ca 2+ currents. UCL 2077 blocks KCNQ1- and KCNQ2-containing K + channels, decreases erg current amplitude, increases erg deactivation rate. UCL 2077 can be used for the research of hippocampus-dependent memory retrieval deficit and cardiac arrhythmias .
loading...
    loading...
Cat. No.: HY-W014883
CAS No.: 2783-17-7
Synonyms: 1,12-DD; 1,12-Diamino dodecane
Research Areas:  

Metabolic Disease

1,12-Dodecanediamine (1,12-DD) is a reversible Maxi calcium-activated potassium channel blocker. 1,12-Dodecanediamine can reduce the single-channel current amplitude, mean channel open time, and channel open probability. 1,12-Dodecanediamine is promising for research of cell electrical signal transduction mechanism .
loading...
    loading...
Cat. No.: HY-N8472
CAS No.: 132196-54-4
Chrodrimanin B, a metabolite of a fungal, is a potent, non-open-channel-blocking antagonist on?B.?mori GABAR RDL with an IC50?of 1.13 nM. Chrodrimanin B attenuates the peak current amplitude of the GABA response of RDL with an IC50?of 1.66 nM.?Chrodrimanin B, a meroterpenoid, shows insecticidal activity .
loading...
    loading...
Cat. No.: HY-176065
CAS No.: 3084825-09-9
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

Nav1.2-IN-1 (compound 5i), a 3-(1,2,3,6-tetrahydropyridine)-4-azaindole derivative, is a potent and selective Nav1.2 inhibitor. Nav1.2-IN-1 induces a reduction in the peak amplitude of Nav1.2 currents with an IC50 value of 7.79 μM. Nav1.2-IN-1 exhibits antiepileptic activity. Nav1.2-IN-1 shows high anticonvulsant effect and low neurotoxicity in subcutaneous Pentetrazole (sc-PTZ)-induced epilepsy mode .
loading...
    loading...
Cat. No.: HY-113673
CAS No.: 1031335-85-9
Purity:  98.77%
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

A-935142 is a human ether-a-go-go-related gene (hERG, Kv 11.1) channel activator. A-935142 enhances hERG current in a complex manner by facilitation of activation, reduction of inactivation, and slowing of deactivation, and abbreviates atrial and ventricular repolarization .
loading...
    loading...
Cat. No.: HY-108502
CAS No.: 181936-98-1
Target:  

Sodium Channel

Research Areas:  

Cardiovascular Disease

KC 12291 hydrochloride is an orally active blocker of voltage-gated sodium channel (VGSC). KC 12291 hydrochloride reduces the amplitude of sustained Na + current to exert antiischemic activity. KC 12291 hydrochloride has significant cardioprotective effect in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-P3777
CAS No.: 109024-47-7
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

β-Bag cell peptide is a neuroactive peptide. β-Bag cell peptide elevates cyclic AMP levels in the bag cell neurons. β-Bag cell peptide decreases the amplitudes of the voltage-dependent potassium currents .
loading...
    loading...
Cat. No.: HY-P1249
CAS No.: 230960-31-3
Research Areas:  

Neurological Disease

Neuropeptide SF (mouse,rat) is a potent neuropeptide FF receptor agonist with Ki values are 48.4 nM and 12.1 nM for NPFF1 and NPFF2, respectively. Neuropeptide SF increases the amplitude of the sustained current of heterologously expressed acid sensing ion channel 3 (ASIC3) .
loading...
    loading...
Cat. No.: HY-P1249A
Research Areas:  

Neurological Disease

Neuropeptide SF (mouse,rat) TFA is a potent neuropeptide FF receptor agonist with Ki values are 48.4 nM and 12.1 nM for NPFF1 and NPFF2, respectively. Neuropeptide SF TFA increases the amplitude of the sustained current of heterologously expressed acid sensing ion channel 3 (ASIC3) .
loading...
    loading...
Cat. No.: HY-131885
CAS No.: 2417096-44-5
Purity:  82.94%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

RuBi-Glutamate hexafluorophosphate sodium is a neuronal activator. RuBi-Glutamate hexafluorophosphate sodium photocleaves to release glutamate upon one- or two-photon excitation, activating glutamate receptors in cortical pyramidal neurons. RuBi-Glutamate hexafluorophosphate sodium reduces peak amplitude of evoked GABAergic inhibitory postsynaptic currents in its caged form. RuBi-Glutamate hexafluorophosphate sodium can be used for the research of Huntington's disease .
loading...
    loading...
Cat. No.: HY-178928
Target:  

Potassium Channel

Research Areas:  

Inflammation/Immunology

KV1.3-IN-3 (Compound 13a) is a KV1.3 channel inhibitor. KV1.3-IN-3 decreases the Kv1.3 peak current amplitude by more than 80%. KV1.3-IN-3 exhibits excellent pharmacological properties and safety. KV1.3-IN-3 can be used for the study of autoimmunity disease .
loading...
    loading...
Cat. No.: HY-108588R
CAS No.: 426834-69-7
NS5806 (Standard) is the analytical standard of NS5806 (HY-108588). This product is intended for research and analytical applications. NS5806, a potent potassium current activator, increases KV4.3/KChIP2 peak current amplitudes with an EC50 of 5.3 μM. NS5806 slows KV4.3 and KV4.2 current dacay in channel complexes containing KChIP2 .
loading...
    loading...
Cat. No.: HY-W699451
MTSET chloride is a membrane-impermeable, thiol-specific reagent that primarily acts as an inhibitor of the Nav1.5 sodium channel. MTSET chloride reduces the peak sodium current amplitude of most mutant Nav1.5 channels, induces a hyperpolarizing shift in steady-state inactivation, and slows the recovery process, but shows no activity against wild-type and non-inactivating Nav1.5 channel mutants. MTSET chloride reacts covalently with T336C mutant P2X2 receptors, partially reversibly blocks ATP-induced cation currents, and exerts no effect on wild-type P2X2 receptors .
loading...
    loading...
Cat. No.: HY-184582
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Kv3.1 activator-2 is a Kv3.1 voltage-gated potassium channel (potassium channel) activator with concentration-dependent activity. Kv3.1 activator-2 opens Kv3.1 potassium channels, increases channel current amplitude, and exerts a positive channel activation effect. Kv3.1 activator-2 can be used in the research of neurological diseases .
loading...
    loading...